|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Early detection of
hypovolemia is clinically important because severe hypovolemia, blood loss of
more than 1 liter, can lead to rapid decline and cardiovascular collapse. By
the time the tachycardia or low blood pressure associated with severe
hypovolemia is finally detected, the patient will already have sever medical
complications. To date, the reliable clinical detection of hypovolemia
requires a pulmonary arterial catheter while under mechanical ventilation, a
procedure which has been associated with medical complications and increased
mortality. The use of these metrics was
validated in nonintubated healthy volunteers with a Lower-Body Negative
Pressure (LBNP) chamber which induces central hypovolemia by sequestering
blood in the hips and lower extremities. Hypovolemia corresponding to
sequestration of more than 1 liter of blood (LBNP > 60 mmHg) was
consistently detected using these metrics before significant change in blood
pressure, or tachycardia are observed. Possible applications of This technology is claimed in the published United
States Patent Application No. 11/624,065. We are seeking an industrial
partner interested in its commercialization. (Ref: J340) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
|
||||
|
|
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|